to view your mail
Yahoo Finance Plus
U.S. markets closed
iRhythm Technologies, Inc. (IRTC)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EDT
335 reactions on $IRTC conversation
Sign in to post a message.
Anyone care to explain the price volatility for the past year or so?
K B B
110s is the bottom ... charts dont lie unless we have a strong earnings to reverse the trend which is very obviously downhill. EA is not happening until May. Best to to bail now or hold out from buying until it settles at the major support level.
-0.33 cents per share earning and 78.8 m rev - OK results
spirit of 76
IRTC getting served with investor lawsuits on a daily basis apparently. A bloated valuation and no pathway the profitability company that never saw the reimbursement train wreck coming it appears.
Any idea when will IRTC be reporting the earnings?
Finally some resistance at 130?
What’s the update? Why is it falling more than the market today?
Hi Shorting guy,
Could you inform us, what is deadline for you to return back the shorted shares. Tired of holding , hold it until it back.
Will it go to 200 back soon?
$200 is still realistic. not worried. people will be dumping all the hype stocks and reinvesting into solid stocks. this will recover just fine. its just not a day trade any more that's all.
Following the Novitas announcement, Robert W. Baird analyst Michael Polark reiterated a Hold rating and $170 price target, said that the rates “look really low” and “way lower than the rates for the T-codes.”
Polark further noted that in Texas zone 18, which he considers an important zone, the rate for CPT code 93247 is set at $42.68 and compares to the old rate for code 0297T in the same zone of “about $311.”
At $42.68 from $311, drop = 86% $250/share => $35/share
At $85 from $311, drop is $72% $250/share => $70/share
This turd is not worth more than $80/share
The firm has just placed a news release which indicates "The Company believes that the published rates by Novitas on January 29, 2021, are crosswalked from CPT codes 93224 and 93226, which are existing CPT codes for external continuous electrocardiographic recording up to 48 hours."
I am upgrading this to 350 with strong buy call. Add
It’s gross to listen to those defending the shorting hedge funds as a balancing force against speculative hype. We have a perfect example here of the back room manipulation pushing out 1/2 truth misstatements and fake lawsuit hype that won’t go anywhere, to make a quick buck by causing sell-side panic and stop-loss avalanche. Taking money from real investors.
I went to buy shares at $238 and it move so fast up it shocked me. That tells me someone is buying not selling shares. I went to add more at $145 and it shot to $157 immediately. If it was going lower they would welcome those buys. Who ever is running this hit wants shares not selling shares. Wish I’d bought 2,000 shares at $140! It’s those 17% short wanting to close and cover before $350 comes. Or simply a buyout is nearing. This isn’t retail trading. 99% is fund trades
hey Robert, sold my position bought at 142 for a $40 a stock gain Just so you know as you were worried about my long position. I am sure this goes higher. Good luck bulls. And Robert go change your pants. No happy meal
For you today :).
Take me up baby, good job to those that bought at $140.
Simply said after meeting and closer review price will be adjusted. This will jump back to $250. What will have happened is those short will have created a way to cover and close position. America
Today we are going to reach $210-220 for sure.
Over reaction to codes that are duplications of existing codes which created a ruckus. Thanks because this will be back over 250 sooner than later. Relax the panicking weak hearts sold us their shares at a big discount Friday. They will make us smile.
Fourth stimulus check: Lawmakers press Biden to say yes to more payments
Amazon workers vote against unionization in Alabama
Yahoo Finance Video
How Elon Musk Responded To Competitor Nio's 100,000th Vehicle Milestone
Advertise with us
© 2021 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research